Individualized Neoantigen Therapy with Unusual Radiotherapy Enhancement (iNATURE)

Clinical trial NCT06314087 · RECRUITING

Trial details

NCT number: NCT06314087
Sponsor: The University of Hong Kong-Shenzhen Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Tumors

Start date: 2024-01-31
Primary completion: 2026-08-16
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.